UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Glen Eagle Advisors LLC

Glen Eagle Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 5,643 shares of the healthcare conglomerate's stock after selling 980 shares during the period. Glen Eagle Advisors LLC's holdings in UnitedHealth Group were worth $2,855,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH traded down $1.30 during trading hours on Friday, reaching $295.37. 16,808,920 shares of the stock traded hands, compared to its average volume of 6,601,348. The company has a market cap of $267.94 billion, a P/E ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's 50-day moving average price is $452.40 and its two-hundred day moving average price is $504.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm earned $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.84%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Insider Transactions at UnitedHealth Group

In other news, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last three months. Insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of analyst reports. Truist Financial reissued a "buy" rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. HSBC restated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.